| Sterility claim | Confirm that the needle is labeled sterile and intended for single use. | Product label, instructions for use, technical file, and applicable regulatory authorization. | The sterile status, single-use symbol, lot number, and expiration date should be clearly identifiable on the package. | Unclear sterility wording, missing expiration date, or packaging that does not identify the product lot. | High |
| Sterilization process | Identify the sterilization method and verify that the process has been validated for the finished packaged product. | ISO 11135 for ethylene oxide, ISO 11137 for radiation, or ISO 17665 for moist heat, when applicable. | Validation should cover the actual product, packaging configuration, load pattern, and claimed shelf life. For terminally sterilized products, a sterility assurance level of 10−6 is commonly used as the target. | Only a statement such as “sterile processed” without a method, validation summary, or release controls. | High |
| Sterile barrier packaging | Inspect the individual blister, pouch, or other sterile barrier for seal integrity and protection from damage. | ISO 11607-1 and ISO 11607-2; packaging integrity and seal-process validation records. | Packaging should be intact, dry, sealed, easy to open aseptically, and protected from puncture or abrasion during transport. | Tears, pinholes, loose seals, delamination, moisture, or packaging that can be opened without clear evidence of seal integrity. | High |
| Shelf life and storage | Check the expiration date, storage conditions, and evidence supporting the claimed shelf life. | Accelerated and real-time aging data; package integrity testing; storage instructions on the label. | The product should remain within specification through the labeled shelf life when stored under the stated temperature, humidity, and light conditions. | Expired or illegible dates, missing storage instructions, or evidence that the package becomes brittle or weak during aging. | High |
| Needle dimensions | Verify gauge, nominal outside diameter, effective length, and compatibility with the intended procedure. | ISO 7864 for sterile single-use hypodermic needles; ISO 9626 for stainless-steel needle tubing, where applicable. | Measured dimensions should comply with the declared specification and be suitable for the intended injection, aspiration, or administration task. | Gauge or length differs from the label, inconsistent dimensions between lots, or a needle that does not fit the intended device. | High |
| Tip and bevel quality | Examine the bevel geometry, sharpness, tip symmetry, burrs, and surface defects. | Dimensional and functional testing under the applicable needle specification; documented visual inspection criteria. | The tip should be clean, sharp, centered, and free from visible burrs, cracks, metal fragments, blocked openings, or rough edges. | Blunt or distorted tip, uneven bevel, visible burrs, blocked lumen, excessive insertion force, or unusual tissue drag. | High |
| Cannula material and surface | Confirm material grade, corrosion resistance, cleanliness, and surface finish. | Material specification; corrosion and cleanliness testing; ISO 7864 or applicable national requirements. | The cannula should be free from visible corrosion, particles, lubricant pools, discoloration, and manufacturing residue. | Rust, flakes, discoloration, visible particles, excessive lubricant, or an undisclosed material change between lots. | High |
| Lubrication | Assess the type, amount, uniformity, and biocompatibility of any lubricant used to reduce friction. | Material safety data, process controls, residue limits, and relevant ISO 10993 biological evaluation. | Lubricant should be medically suitable, consistently applied, and not visibly pooled or transferred in excessive amounts. | Unknown lubricant, visible droplets, inconsistent coating, unexpected irritation, or no control of lubricant residue. | Medium |
| Hub and connection security | Check hub attachment, leakage resistance, connector fit, and dimensional compatibility. | ISO 7864 and applicable connector requirements; leak, tensile, and connection-force test records. | The hub should be firmly attached, free from cracks, compatible with the intended syringe or device, and resistant to leakage during use. | Loose hub, cracking, wobbling, leakage, difficult connection, or unexplained incompatibility with standard fittings. | High |
| Safety mechanism | Determine whether a safety shield, sliding cover, hinged guard, or other sharps-injury prevention feature is required. | Applicable national sharps-safety regulations; usability and performance testing for the complete needle system. | The mechanism should activate reliably, remain locked or stable after activation, and allow the intended procedure without obstructing visibility. | Guard activates accidentally, fails to cover the sharp completely, requires unsafe hand positioning, or is incompatible with the workflow. | High |
| Passive versus active protection | Compare whether the protection activates automatically or requires a deliberate user action. | Risk-management file, human-factors validation, and documented use-error analysis. | Passive protection may reduce dependence on user action; active protection should have clear activation feedback and a low failure risk. | Safety feature is difficult to understand, cannot be activated with one hand when required, or has no evidence of usability testing. | High |
| Biocompatibility | Evaluate patient-contacting materials, residues, coatings, adhesives, and processing aids. | ISO 10993 biological evaluation based on contact type, duration, and intended clinical use. | The biological evaluation should address the finished device, including sterilization residues and lubricants, rather than only the raw material. | Biocompatibility evidence covers only a raw material, omits patient-contacting coatings, or does not reflect the intended route of use. | High |
| Particulate and endotoxin control | Review controls for visible particles, subvisible particles, bacterial endotoxins, and manufacturing cleanliness. | Validated cleanliness and endotoxin methods appropriate to the product and intended route of administration. | The product should meet the applicable pharmacopoeial or regulatory limits for its intended use; limits are route- and product-specific. | Generic “clean” claims without test methods, visible debris, or endotoxin limits that are not linked to the intended clinical application. | High |
| Manufacturing quality system | Assess process control, inspection, nonconformance handling, corrective actions, and supplier controls. | ISO 13485 certification or equivalent quality-system evidence, subject to the applicable jurisdiction. | Critical processes such as grinding, cleaning, assembly, packaging, and sterilization should be controlled and traceable. | No documented quality system, repeated unexplained defects, or inability to provide lot-specific quality records. | High |
| Lot traceability | Confirm that each package can be traced to manufacturing, sterilization, inspection, and distribution records. | Lot or batch number, production date, expiration date, and applicable device-identification requirements. | Traceability should support rapid investigation, targeted recall, complaint handling, and verification of the supplied specification. | Missing lot number, mismatched labels, unreadable barcodes, or inability to link the product to sterilization records. | High |
| Labeling and instructions | Review gauge, length, intended use, sterile status, single-use statement, warnings, storage conditions, and disposal instructions. | ISO 15223-1 symbols and applicable labeling regulations in the destination market. | Information should be legible, consistent across the individual package and outer carton, and sufficient for safe selection and disposal. | Ambiguous size notation, missing warnings, conflicting information, or symbols without adequate explanation where required. | High |
| User handling and packaging usability | Evaluate opening force, grip, visibility, presentation, and risk of accidental contact with the sterile needle. | Human-factors or usability evaluation for the intended user population and clinical environment. | Packaging should support aseptic presentation and minimize needle contact, dropped components, and confusion between sizes. | Needle springs out of the package, sterile surface is difficult to access, or similar sizes are easily confused. | Medium |
| Sampling and incoming inspection | Establish a documented inspection plan for incoming lots instead of relying only on supplier claims. | Risk-based sampling plan, certificate review, visual inspection, dimensional checks, and complaint trend review. | Sampling levels and acceptance criteria should be defined before inspection; critical defects should have zero-tolerance handling appropriate to risk. | Unspecified sampling, acceptance based only on appearance, or use of an AQL value without a defined sampling standard and defect classification. | Medium |
| Environmental and disposal considerations | Consider packaging efficiency, material disclosure, disposal instructions, and sharps-container compatibility. | Applicable waste-management, occupational-safety, and environmental requirements. | Used needles should be disposed of immediately in an approved sharps container; recycling claims should not compromise infection or sharps safety. | Instructions encourage recapping, disposal guidance is absent, or environmental claims are unsupported by material and process data. | Medium |
Reliability
Integrity
Teamwork
Looking for the 
Register as